JAC Advance Access originally published online on May 2, 2006
Journal of Antimicrobial Chemotherapy 2006 58(1):178-182; doi:10.1093/jac/dkl178
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Emergence of PER and VEB extended-spectrum ß-lactamases in Acinetobacter baumannii in Belgium
1 Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI 78 rue du Général Leclerc, 94275 K.-Bicêtre, France 2 Laboratoire de Bactériologie, Cliniques Universitaires UCL de Mont-Godinne Belgium
Received 27 February 2006; returned 3 April 2006; revised 7 April 2006; accepted 10 April 2006
*Corresponding author. Tel: +33-1-45-21-29-86; Fax: +33-1-45-21-63-40; E-mail: thierry.naas{at}bct.ap-hop-paris.fr
Objectives: Strains of Acinetobacter baumannii producing the extended-spectrum ß-lactamase (ESBL) PER-1 are widespread in Turkey and have also been reported from Korea and France. In contrast, A. baumannii producing the ESBL VEB-1 have only been reported from France, where one strain was responsible for a nationwide outbreak in 2003–2004. Here we describe the emergence of strains of A. baumannii producing VEB-1 and PER- 1 in Belgium.
Methods: Belgian hospitals were alerted in December 2003 to the emergence in France of VEB-1-producing A. baumannii susceptible only to meropenem and colistin. Isolates with a compatible susceptibility profile were sent to a single central laboratory for VEB-1 confirmation, molecular characterization and typing.
Results: From December 2003 to March 2005, three hospitals located close to the French border and one in the Brussels area reported isolation of eight A. baumannii isolates compatible with the French epidemic clone. Using PCR, six were identified as VEB-1-positive and two as PER-1-positive. All the VEB-1-positive isolates were clonally related by PFGE and by integron analysis to the French epidemic strain. The PER-1-positive strains were indistinguishable by PFGE but not related to the known French isolate or to several Turkish isolates. Both genes were chromosomally encoded.
Conclusions: This work illustrates the inter-country spread of VEB-1-producing A. baumannii isolates as well as the emergence of PER-1-producing A. baumannii strains in Belgium.
Keywords: ESBLs , inter-country spread , outbreak , multidrug resistance
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Zong, S. R. Partridge, and J. R. Iredell A blaVEB-1 Variant, blaVEB-6, Associated with Repeated Elements in a Complex Genetic Structure Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1693 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Boo, F. Walsh, and B. Crowley Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3 J. Med. Microbiol., February 1, 2009; 58(2): 209 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Livermore, S. Mushtaq, M. Warner, C. Miossec, and N. Woodford NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum {beta}-lactamases and carbapenemases J. Antimicrob. Chemother., November 1, 2008; 62(5): 1053 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zong, S. R. Partridge, L. Thomas, and J. R. Iredell Dominance of blaCTX-M within an Australian Extended-Spectrum {beta}-Lactamase Gene Pool Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4198 - 4202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zong, S. R. Partridge, and J. R. Iredell RmtC 16S rRNA Methyltransferase in Australia Antimicrob. Agents Chemother., February 1, 2008; 52(2): 794 - 795. [Full Text] [PDF]
|
|
|
|
|
|
F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo Global Challenge of Multidrug-Resistant Acinetobacter baumannii Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3471 - 3484. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Empel, K. Filczak, A. Mrowka, W. Hryniewicz, D. M. Livermore, and M. Gniadkowski Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum {beta}-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal Complex J. Clin. Microbiol., September 1, 2007; 45(9): 2829 - 2834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Coelho, J. F. Turton, M. E. Kaufmann, J. Glover, N. Woodford, M. Warner, M.-F. Palepou, R. Pike, T. L. Pitt, B. C. Patel, et al. Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England. J. Clin. Microbiol., October 1, 2006; 44(10): 3623 - 3627. [Abstract] [Full Text] [PDF]
|
|